/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Associate Prof Kevin Damman, MD, PhD, FHFA, studied medicine at the University of Groningen, The Netherlands and received his PhD in 2009 entitled “Cardiorenal Interaction in Heart Failure”. Dr Damman is a clinical cardiologist, Medical Director of the heart transplant and ventricular assist device program at the UMCG, Groningen, The Netherlands. His interests include advanced and acute heart failure. Current research interests are focused on improving treatment of acute heart failure patients, including SGLT2-inhibition in (acute) heart failure and the role of the kidney in the process of cardiorenal interaction. He was co-PI of the PUSH-AHF study on natriuresis guided treatment in acute heart failure and was part of the steering committee of the ADVOR trial investigating acetazolamide in acute heart failure. Dr Damman is associate editor of the European Journal of Heart Failure and is Chair of the working group on Advanced Heart Failure from the HFA.
